Genomics Market Report 2026

Genomics Market Overview

• Genomics market size has reached to $50.23 billion in 2025 • Expected to grow to $107.56 billion in 2030 at a compound annual growth rate (CAGR) of 16.5% • Growth Driver: Government Funding Boosts Genomics Research • Market Trend: Advancements In Long-Read Technology For Enhanced Genome Sequencing And Analysis • North America was the largest region in 2025 and Western Europe is the fastest growing region.

The key promising market opportunities in the genomics market include: • Reagents (Segmentation By By Product Type) → Expected gain of $30.53 Billion • Instrument (Segmentation By By Product Type) → Expected gain of $26.19 Billion

What Is Covered Under Genomics Market?

Genomics refers to the study of the complete set of genes (genome) within an organism, including their structure, function, evolution, and mapping. It involves analyzing the sequencing and interactions of DNA, RNA, and proteins to understand how genes regulate biological processes and contribute to traits and diseases. Genomics plays a crucial role in fields like medicine, agriculture, and biotechnology, helping to advance personalized medicine, improve crop yields, and develop targeted therapies for genetic disorders. The main product types of genomics are instrument (including systems, service contract and software), reagents (including reagents and consumables). A reagent is a substance or compound that is added to a system in order to produce a chemical reaction or to determine whether or not a reaction occurred. The different processes include cell isolation, sample preparation, and genomic analysis that are used by academic institutes, biopharmaceutical companies, and clinical research institutes.

What Is The Genomics Market Growth Forecast?

The genomics market size is expected to see rapid growth in the next few years. It will grow to $107.56 billion in 2030 at a compound annual growth rate (CAGR) of 16.5%. The growth in the forecast period can be attributed to population genomics initiatives, integration with healthcare systems, expansion of agricultural genomics, increased biopharma investment, development of multi-omics platforms. Major trends in the forecast period include expansion of large-scale genomic research programs, increasing adoption of next-generation sequencing, growing demand for precision medicine solutions, rising use of genomics in drug discovery, increased investment in genomic infrastructure.

What Is The Driver Of The Genomics Market?

Rising government funds for research on genomics drive the growth of the single-cell genomics market. The government funding focuses on efforts to resolve the complexity of the human genome, define the genomic basis of human health and disease, and ensure that genomics is used safely to enhance patient care and benefit society through government, public, and private institutions. For instance, in March 2024, according to the National Human Genome Research Institute, a US-based government research institute, the FY 2025 President’s Budget request for the National Human Genome Research Institute (NHGRI) is $663.7 million, an increase of $3.2 million compared with the FY 2023 final level. Therefore, rising government funds for research on genomics are expected to raise the genomics industry.

How Will The Drivers Impact Growth In The Global Genomics Market?

• Rising Adoption Of Genomics In Drug Discovery And Development (High) – During the forecast period, the rising adoption of genomics in drug discovery and development is expected to become a key growth driver for the genomics market by 2030. Pharmaceutical and biotechnology companies are increasingly leveraging genomic insights to identify novel therapeutic targets, understand disease mechanisms, and improve clinical trial success rates. Genomics-enabled approaches support the development of more effective therapies while reducing research timelines and development costs. The growing use of genomic data in biomarker identification and target validation is further strengthening its role across the drug development pipeline. • Increasing Demand For Personalized Medicine (High) – During the forecast period, the increasing demand for personalized medicine is expected to emerge as a major factor driving the expansion of the genomics market by 2030. Healthcare providers are increasingly utilizing genomic information to tailor treatment strategies based on individual genetic profiles, improving therapeutic outcomes and minimizing adverse effects. The growing prevalence of chronic diseases and complex disorders is accelerating the adoption of precision medicine approaches across healthcare systems. In addition, expanding awareness among patients and clinicians regarding individualized treatment solutions is supporting broader implementation of genomic testing. • Technological Advancements In Sequencing Technologies (High) – During the forecast period, the technological advancements in sequencing technologies are expected to act as a key growth catalyst for the genomics market by 2030. Continuous improvements in sequencing speed, throughput, and analytical performance are enabling broader accessibility of genomic applications across research and clinical settings. Advanced platforms are facilitating large-scale genomic studies while supporting more comprehensive and reliable genetic analysis. The ongoing development of automated workflows and integrated bioinformatics solutions is further enhancing operational efficiency and scalability.

How Will The Restraints Impact Growth In The Global Genomics Market?

• High Cost Of Genomic Technologies And Sequencing (High) – During the forecast period, the high cost of genomic technologies and sequencing acts as a major restraint for the genomics market by limiting accessibility for small and mid-sized research organizations and healthcare providers. Advanced sequencing platforms, reagents, and data analysis tools require substantial capital investment, increasing the overall cost burden. This restricts adoption in emerging markets where funding and infrastructure are limited. Additionally, high operational and maintenance costs reduce scalability for routine clinical use. As a result, the widespread commercialization and penetration of genomics solutions are slowed. • Data Privacy Concerns And Ethical Issues (High) – During the forecast period, the data privacy concerns and ethical issues act as significant restraints for the genomics market by creating hesitation among individuals and institutions to share genetic information. Genomic data is highly sensitive, and risks related to misuse, data breaches, and unauthorized access raise serious concerns. Strict regulations around data protection increase compliance complexity and operational costs for companies. Ethical debates surrounding genetic modification and testing further slow acceptance in certain regions. Consequently, these concerns hinder data-driven research and limit the expansion of genomics applications. • Lack Of Skilled Professionals And Technical Expertise (High) – During the forecast period, the lack of skilled professionals and technical expertise acts as a key restraint for the genomics market by creating gaps in the effective use and interpretation of complex genomic data. Genomics requires specialized knowledge in bioinformatics, molecular biology, and data analytics, which are in short supply globally. This talent shortage slows down research progress and delays clinical implementation of genomic solutions. Organizations also face increased costs in training and hiring qualified personnel. As a result, the growth and operational efficiency of the genomics market are significantly impacted.

Key Players In The Global Genomics Market

Major companies operating in the genomics market are 10X Genomics Inc., Qiagen NV, Standard BioTools Inc., Illumina Inc., Affymetrix Inc., Angle plc, Denovo Sciences Inc., Diagnologix LLC, DNA Electronics Ltd., Epic Sciences, Kellbenx Inc., Resolution Bioscience Inc., Wafergen Bio-systems Inc., Yikon Genomics Co. Ltd., Thermo Fisher Scientific Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Cell Microsystems Inc., CellSorter, CYTENA GmbH, Dolomite Bio Limited, Agilent Technologies Inc., Fluxion Biosciences Inc., BGI Group, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Eurofins Scientific SE, PerkinElmer Inc.

Global Genomics Market Trends and Insights

Major companies operating in the genomics market are focused on technological advancements such as long read technology to enhance genome sequencing accuracy, enable the analysis of larger and more complex genetic regions, and provide deeper insights into genetic variations that were previously difficult to detect. Long read technology in genomics involves sequencing longer DNA or RNA segments for more precise and complete genetic analysis, enabling better detection of complex variations and disease-related markers. For instance, in March 2023, Illumina Inc., a US-based biotechnology company, launched Illumina's Complete Long Read Prep. It provides an efficient, low-input solution for whole-genome sequencing, offering both long- and short-read data on the same device, with simplified workflows and fewer required materials compared to other technologies.

What Are Latest Mergers And Acquisitions In The Genomics Market?

In July 2024, Petrosys Pty Ltd, an Australia-based software company, acquired Talus Technologies Inc. for an undisclosed amount. With this acquisition, Petrosys Pty Ltd aims to provide advanced software solutions for the energy and resource industries, focusing on improving data visualization. Talus Technologies Inc. is a Canada-based company, focusing on the discovery and development of therapeutics that target transcription factors (TFs).

What Defines the Genomics Market?

The genomics market consists of sales of genomics such as structural genomes, functional genomes, mutation genomics and comparative genomics that are used for drug discovery and development. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Genomics Market Report 2026?

The genomics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the genomics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.